MedPath

Comparing the effect of single dose of rectal Indomethacin and oral Melatonin on prevention of post ERCP pancreatitis

Phase 4
Conditions
pancreatitis.
Acute pancreatitis
Registration Number
IRCT20121021011192N6
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients undergoing ERCP in Taleghani hospital by taking written consen

Exclusion Criteria

Patients history of hypersensitivity against each of melatonin, indomethacin or diclofenac
Active peptic ulcer diseases
Renal impairment (GFR < 10 ml/min)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of pancreatitis. Timepoint: 10 days after intervention. Method of measurement: Clinical evaluation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath